Skip to content
10-Q

Quarterly Report

SKINOVATION PHARMACEUTICAL INCORPORATED

0001554795-21-000181

← back to feed
Filed
May 17, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2021 · May 17, 2021 708K sh
Current Liabilities Q1 2021 · Mar 31, 2021 $357K
Current Liabilities Q1 2021 · Dec 31, 2020 $348.69K
Total Liabilities Q1 2021 · Mar 31, 2021 $357K
Total Liabilities Q1 2021 · Dec 31, 2020 $348.69K
Current Assets Q1 2021 · Mar 31, 2021 $1.85K
Current Assets Q1 2021 · Dec 31, 2020 $3.55K
Total Assets Q1 2021 · Mar 31, 2021 $1.85K
Total Assets Q1 2021 · Dec 31, 2020 $3.55K
Operating Cash Flow Q1 2021 · Mar 31, 2020 −$1.22K
Cash And Equivalents Q1 2021 · Mar 31, 2020 $62
Cash And Equivalents Q1 2021 · Dec 31, 2019 $77
Stockholders Equity Q1 2021 · Mar 31, 2020 −$323.79K
Stockholders Equity Q1 2021 · Dec 31, 2019 −$314.19K
Sga Expense Q1 2021 · Mar 31, 2020 $5.42K
Net Income Q1 2021 · Mar 31, 2020 −$9.6K
Operating Income Q1 2021 · Mar 31, 2020 −$5.42K